Quantcast
Last updated on April 18, 2014 at 6:54 EDT

Latest Pneumococcal vaccine Stories

2012-01-30 08:12:12

Genetics has provided surprising insights into why vaccines used in both the UK and US to combat serious childhood infections can eventually fail. The study, published today in Nature Genetics, which investigates how bacteria change their disguise to evade the vaccines, has implications for how future vaccines can be made more effective. Pneumococcus (Streptococcus pneumoniae) causes potentially life-threatening diseases including pneumonia and meningitis. Pneumococcal infections are...

2012-01-18 10:44:01

Grant MacKenzie of the MRC Unit in The Gambia and colleagues describe in this week's PLoS Medicine how they set up a population-based surveillance system to assess the impact of pneumococcal conjugate vaccines (PCVs) on invasive pneumococcal disease (IPD) and radiological pneumonia in children in The Gambia. The surveillance system is expected to inform immunisation policy and serves as a potential model for those introducing routine PCV vaccination in diverse settings. The authors state:...

2011-12-30 12:56:00

SILVER SPRING, Md., Dec. 30, 2011 /PRNewswire-USNewswire/ -- Prevnar 13, a pneumococcal 13-valent conjugate vaccine, was approved today by the U.S. Food and Drug Administration for people ages 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Pneumococcal pneumonia, caused when the bacterium Streptococcus pneumoniae infects the lungs, is the most common disease...

2011-12-22 10:23:26

Check-list for a healthy life: Quit smoking. Don't drink too much. Exercise regularly. Oops! You forgot something — up-to-date immunizations. Adult Canadians are not being immunized routinely for life-saving, vaccine-preventable diseases, according to Dr. Vivien Brown, an adjunct associate professor of McMaster University's Michael G. DeGroote School of Medicine who lectures extensively to doctors and other health care professionals across Canada. The family physician said a...

2011-11-10 12:56:38

Advances lauded as Malawi becomes next developing country to introduce pneumococcal vaccine on Saturday -- World Pneumonia Day Vaccines against the primary cause of deaths from pneumonia in developing countries could save millions of lives and are highly cost-effective, according to a comprehensive new analysis to be released on Thursday, Nov. 10. In a paper published in the journal International Health, the authors estimate that two pneumococcal vaccines being introduced in the world's...

2011-10-19 05:31:58

(Ivanhoe Newswire) — Vaccinating young children against pneumonia in turn will protect the entire community.   In a randomized, controlled trial involving 21 villages in rural Gambia, the authors showed that vaccination of young children reduced carriage of vaccine serotype pneumococci (the type of pneumoccus contained in the vaccine) not only in the vaccinated children but also in vaccinated and non-vaccinated older children and adults. Furthermore, the study showed that...

2011-09-22 21:21:26

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how a novel type of antibody works against pneumococcal bacteria. The findings, which could improve vaccines against pneumonia, appear in the September/October issue of mBio, the online journal of the American Society for Microbiology. Until recently, scientists thought that antibodies work against pneumococcal bacteria by killing them with the help of immune cells. However, several years ago, Einstein...

9cead16037c31effa279a502d22dd59d
2011-07-07 14:05:59

By Richard Harth, The Biodesign Institute On July 8, at approximately 11:26 a.m. EDT, the space shuttle Atlantis will streak skyward from the Kennedy Space Center's launch pad 39A, for one last mission. While the STS-135 flight marks the end of the space shuttle's glory days, its final trip may open a new era of research into infectious diseases, thanks to space bound experiments conducted by Dr's. Cheryl Nickerson, and Roy Curtiss III, along with their colleagues at Arizona State...

b1ca5215bfb6f45f0474729f087b23d8
2011-06-30 09:20:09

By Richard Harth, The Biodesign Institute A powerful new class of therapeutics, known as recombinant attenuated Salmonella vaccines (RASV), holds great potential in the fight against fatal diseases including hepatitis B, tuberculosis, cholera, typhoid fever, AIDS and pneumonia. Now, Qingke Kong and his colleagues at the Biodesign Institute at Arizona State University, have developed a technique to make such vaccines safer and more effective. The group, under the direction of Dr. Roy Curtiss,...

7fd987f7838d2c2979d0638f44f6fb98
2011-06-14 05:50:00

$4.3 billion has been pledged by international donors, led by Britain and Bill Gates, to buy vaccines that help protect children in poor countries against life-threatening diseases such as pneumonia and diarrhea, a London conference announced on Monday. Global Alliance for Vaccines and Immunization (GAVI), which is supported by Microsoft's Bill Gates, says the funding would save more than four million lives in the next four years, by providing more than 250 million of the world's poorest...